Potential side effects to GLP-1 agonists: Understanding their safety and tolerability
Eating protein first ensures you get the most important part of the meal before appetite fades
Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders
The inclusion of affiliate links does not influence the editorial integrity, research process, or outcome of product evaluations
Dizziness is a common complaint that can be caused by a variety of factors, ranging from dehydration to more serious medical conditions